Related Experiment Videos
Apraclonidine prophylaxis for postcycloplegic intraocular pressure spikes
R A Hill1, D S Minckler, M Lee
1Department of Ophthalmology, University of California, College of Medicine, Irvine 92717.
Ophthalmology
|July 1, 1991
Summary
Apraclonidine effectively reduces dangerous intraocular pressure spikes after cycloplegia in open-angle glaucoma patients. This study confirms its benefit in preventing post-procedure eye pressure elevations.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Pharmacology
Background:
- Elevated intraocular pressure (IOP) spikes post-cycloplegia are a risk in open-angle glaucoma patients.
- Understanding and mitigating these spikes is crucial for patient eye health.
Purpose of the Study:
- To assess the incidence of postcycloplegic IOP spikes in open-angle glaucoma.
- To evaluate the efficacy of apraclonidine in preventing these IOP spikes.
Main Methods:
- A randomized, prospective, double-masked study.
- Patients with open-angle glaucoma were stratified by miotic treatment status.
- Participants received either apraclonidine or placebo before tropicamide instillation.
Main Results:
- A high incidence of clinically significant IOP spikes (≥6 mmHg) occurred in placebo groups (37-38%).
- Apraclonidine significantly reduced postcycloplegic IOP compared to placebo (P=0.003 and P=0.006).
- Fewer eyes experienced spikes >10 mmHg with apraclonidine versus placebo.
Conclusions:
- Apraclonidine is effective in minimizing IOP spikes after cycloplegia in glaucoma patients.
- It offers a valuable prophylactic measure for eyes susceptible to cycloplegia-induced pressure increases.